If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
You need a JavaScript-enabled browser to view this Publication
Please follow these steps to view the Publication:
Enable JavaScript in your browser
Refresh this page
Best regards
Zmags
NAROPIN® delivers
a faster return
of motor function
than bupivacaine.1,2
A Block Well Done.
NAROPIN provides 8 to 10 hours
faster return of motor function
following total knee replacement
than bupivacaine (P<0.05).1
To learn more about the clinical benefits
of NAROPIN, visit www.naropin-us.com.
WHY COMPROMISE?
NAROPIN is indicated for the production of regional or local anesthesia for surgery and for acute pain management.
References: 1. Beaulieu P, Babin D, Hemmerling T. The pharmacodynamics of ropivacaine and bupivacaine in combined
sciatic and femoral nerve blocks for total knee arthroplasty. Anesth Analg. 2006;103:768-774. 2. Morrison LM,
Emanuelsson BM, McClure JH, et al. Efficacy and kinetics of extradural ropivacaine: comparison with bupivacaine.
Br J Anaesth. 1994;72:164-169.
Using NAROPIN beyond recommended doses to increase motor block or duration of se
NAROPIN® delivers a faster return of motor functi
Naropin® (ropivacaine HCl) Injection Brief Summar
Register online! 15thAnnual Be st Val u e f f o
There's Still Time to Secure Your Spot… don't mis
Volume 75, Number 10 October 2011
Is Fiberoptic Intubation separately billable for
from the crow’s nest Pierre Robin and Anna
These pioneers developed the equipment
administrative update Investing in Our Future Le
Current Award Recipients (Mentor/Mentee): n Armi
ASA executive office report ASA’s Newest Member B
Right Where The Action Is Core Readings. Real Tim
Pediatric Anesthesia: A Historical Perspective T
continued from page 11 provided therapeutic a
As popularity of this young subspecialty blo
Organizational Support for Pediatric Anesthesia:
procedures. The Section meets twice annually, onc
continued from page 15 Society for Pediatric Anes
Examp e o lf r
Quality Improvement Initiatives in Pediatric Anes
a standardized case analysis is completed. The r
continued from page 19 As a first step, represent
New & Refurbished Anesthesia Equipment Ne
lewis h. wright memorial lecture Jeffrey B. Coope
During this decade, Dr. Cooper was also on
continued from page 23 was at the forefront of th
Invented by Hakko Medical
Walter Reed-Bethesda Merger John A. Hodgson, M.D
65th Annual PostGraduate Assembly in Anesthesio
2012 Relative Value Guide®, CROSSWALK® and Revers
ASA CROSSWALK The ASA CROSSWALK lists CPT proc
what’s new in ... On October 1, 2011, the Anesth
Detailed
Continued from page 30 not go away. The Austra
Legal protection is conferred by our standing
Is Fiberoptic Intubation separately billable for
Self-Education and Evaluation SEE Question Acc
committee news Professional Liability Insurance
Figure 2 requiring pain physicians to have had f
practice management Based on the 2011 ASA commer
Methodology The survey was disseminated beginn
Continued from page 39 Table 2: Regional Managed
Observations Here are some of the salient poin
state beat The Missouri Association of Nurse
appellants are entitled to an injunction prohibit
The Function of SNACC subspecialty news Monica
medical education. Our international member
residents’ review Ashish K. Khanna, M.D. The m
Table 1: Characteristics of the Critical Care and
ACE Question Which of the following factors is M
Organizational Support for Pediatric Anesthesia c
asa news The American Board of Anesthesiology-AS
Issue 8B Available Now! Test your knowledge of an
2012 Relative Value Guide® & CROSSWALK®
55
FAER Report Why I Give My Time and Money to FAER
and generally have a strong research background a
REGISTER NOW! January 27-29, 2012 Buena Vista P
Walter Reed-Bethesda Merger continued from page 2
NE WSLETTER INDUSTRY PARTNER 2011 Classified
Can you afford to be complacent about your billin
Learn more about the clinical benefits of NAROPIN®
Can you afford to be complacent about your billin